Fintel reports that on February 24, 2025, Goldman Sachs downgraded their outlook for Conagra Brands (NYSE:CAG) from Buy to ...
Stifel Nicolaus analyst Matthew Smith, CFA maintained a Hold rating on Conagra Brands (CAG – Research Report) on February 23 and set a price ...
Shares of Conagra Brands, Inc. (NYSE:CAG – Get Free Report) have earned a consensus rating of “Hold” from the ten research ...
Companies argue they’re filling a need created by these miracle weight-loss drugs. But are they offering something of real value — or simply taking advantage of another food fad?
This was the stock's second consecutive day of gains.
Conagra is facing significant operational challenges, but the valuation is now compelling enough to reward buyers despite the ...
Louisiana State Employees Retirement System reduced its position in Conagra Brands, Inc. (NYSE:CAG – Free Report) by 4.8% in ...
Consequently, food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...
Helping to support the fervor has been strong profit reports from Entergy and other big U.S. businesses. Companies in the S&P ...
The company said it noticed product quality inconsistencies, so production has been slowed down as adjustments are being made at the plant where chicken is cooked and processed for frozen meals.